Definition:
The Wound Care market consists of a comprehensive array of over-the-counter (OTC) solutions. These solutions are aimed at managing wounds, promoting healing, and preventing infections. The product offerings encompass adhesive bandages for minor wound coverage, first aid kits providing extensive supplies, gauze and tape for maintaining cleanliness, as well as wound healing ointments that support the recovery of damaged skin and wounds. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Wound Care market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
The Wound Care market in Benelux is experiencing steady growth due to increasing customer preferences for advanced wound care products and the presence of local special circumstances that drive market demand. Customer preferences in the Benelux region are shifting towards advanced wound care products that offer faster healing and improved patient comfort. This trend is driven by the growing awareness among healthcare professionals and patients about the benefits of advanced wound care solutions. Customers in Benelux are increasingly opting for products such as wound dressings, wound closure devices, and wound care biologics that promote faster healing and reduce the risk of infection. Additionally, there is a growing demand for products that provide pain relief and minimize scarring, further driving the adoption of advanced wound care solutions.The market in Benelux is also influenced by local special circumstances that contribute to its development. The region has a well-established healthcare infrastructure with advanced medical facilities and a high level of healthcare expenditure. This enables the availability and accessibility of a wide range of wound care products. Furthermore, the aging population in Benelux is a significant factor driving market growth, as elderly individuals are more prone to chronic wounds and require specialized wound care products. The prevalence of chronic diseases such as diabetes and obesity also contributes to the demand for wound care solutions in the region.In addition to customer preferences and local special circumstances, there are underlying macroeconomic factors that support the growth of the Wound Care market in Benelux. The region has a stable economy and a high standard of living, which allows individuals to afford advanced wound care products. Moreover, the presence of a well-regulated healthcare system ensures that these products meet the necessary quality and safety standards, instilling confidence among customers and healthcare professionals. The government in Benelux also plays a crucial role in promoting the development of the healthcare sector and investing in research and development of innovative wound care solutions.Overall, the Wound Care market in Benelux is witnessing growth due to customer preferences for advanced wound care products, local special circumstances that drive market demand, and underlying macroeconomic factors that support the development of the healthcare sector. As the region continues to prioritize healthcare advancements and invest in research and development, the Wound Care market in Benelux is expected to grow further in the coming years.
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights